{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:48:01Z","timestamp":1790628481421,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:00:00Z","timestamp":1337040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1208\/s12249-012-9798-z","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T15:36:15Z","timestamp":1337009775000},"page":"760-771","source":"Crossref","is-referenced-by-count":16,"title":["Miconazole Nitrate Oral Disintegrating Tablets: In Vivo Performance and Stability Study"],"prefix":"10.1208","volume":"13","author":[{"given":"Tarek A.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"El-Say","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged F.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia A.","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"issue":"3","key":"9798_CR1","first-page":"Article-008","volume":"5","author":"KS Himanshu","year":"2010","unstructured":"Himanshu KS, Tarashankar B, Jalaram HT, Chirag AP. Recent advances in granulation technology. Int J Pharm Sci Rev Res. 2010;5(3):Article-008.","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"2","key":"9798_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1517\/17425247.2011.548382","volume":"8","author":"N Sandler","year":"2011","unstructured":"Sandler N, Lammens RF. Pneumatic dry granulation: potential to improve roller compaction technology in drug manufacture. Expert Opin Drug Deliv. 2011;8(2):225\u201336.","journal-title":"Expert Opin Drug Deliv"},{"key":"9798_CR3","unstructured":"Powder pro (2012) \n                    http:\/\/www.powderpro.se\/products\/technology\/\n                    \n                  . Accessed 8 Apr 2012."},{"issue":"2","key":"9798_CR4","first-page":"132","volume":"8","author":"L Ochoa","year":"2005","unstructured":"Ochoa L, Igartua M, Hern\u00e1ndez RM, Gasc\u00f3n AR, Pedraz JL. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J Pharm Pharm Sci. 2005;8(2):132\u201340.","journal-title":"J Pharm Pharm Sci"},{"issue":"1\u20132","key":"9798_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0378-5173(02)00189-8","volume":"242","author":"L Rodriguez","year":"2002","unstructured":"Rodriguez L, Cavallari C, Passerini N, Albertini B, Gonz\u00e1lez-Rodr\u00edguez M, Fini A. Preparation and characterization by morphological analysis of diclofenac\/PEG 4000 granules obtained using three different techniques. Int J Pharm. 2002;242(1\u20132):285\u20139.","journal-title":"Int J Pharm"},{"issue":"11","key":"9798_CR6","first-page":"62","volume":"33","author":"U Ismat","year":"2009","unstructured":"Ismat U, Jennifer W, Shih-Ying C, Gary JW, Nemichand BJ, San K. Moisture activated dry granulation\u2014part I: a guide to excipient and equipment selection and formulation development. Pharm Technol. 2009;33(11):62\u201370.","journal-title":"Pharm Technol"},{"issue":"1\u20132","key":"9798_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijpharm.2008.02.002","volume":"357","author":"HL Lin","year":"2008","unstructured":"Lin HL, Ho HO, Chen CC, Yeh TS, Sheu MT. Process and formulation characterizations of the thermal adhesion granulation (TAG) process for improving granular properties. Int J Pharm. 2008;357(1\u20132):206\u201312.","journal-title":"Int J Pharm"},{"key":"9798_CR8","unstructured":"Paul J, Shesky R, Colin K. New foam binder technology from Dow improves granulation process. Pharm Can. 2006; 19\u201322."},{"key":"9798_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.2042-7158.1993.tb05588.x","volume":"45","author":"S Bouckaert","year":"1993","unstructured":"Bouckaert S, Remon JP. In vitro bioadhesion of a buccal, miconazole slow release tablets. J Pharm Pharmacol. 1993;45:504\u20137.","journal-title":"J Pharm Pharmacol"},{"key":"9798_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1081\/DDC-100102225","volume":"25","author":"P Minghetti","year":"1999","unstructured":"Minghetti P, Cilurzo F, Casiraghi A, Molla FA, Montanari L. Dermal patches for the controlled release of miconazole: influence of the drug concentration on the technological characteristics. Drug Dev Ind Pharm. 1999;25:679\u201384.","journal-title":"Drug Dev Ind Pharm"},{"key":"9798_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0939-6411(00)00124-7","volume":"50","author":"TK Mandal","year":"2000","unstructured":"Mandal TK. Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm. 2000;50:337\u201343.","journal-title":"Eur J Pharm Biopharm"},{"key":"9798_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3109\/03639049109043835","volume":"17","author":"M Pedersen","year":"1991","unstructured":"Pedersen M, Rassing MR. Miconazole chewing gum as a drug delivery system: test of release promoting additives. Drug Dev Ind Pharm. 1991;17:411\u201320.","journal-title":"Drug Dev Ind Pharm"},{"key":"9798_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF01740659","volume":"43","author":"S Bouckaert","year":"1992","unstructured":"Bouckaert S, Schautteet H, Lefebvre RA, Remon JP, van Clooster R. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur J Clin Phamacol. 1992;43:137\u201340.","journal-title":"Eur J Clin Phamacol"},{"key":"9798_CR14","volume-title":"Stability testing of new drug substances and products","author":"ICH","year":"1993","unstructured":"ICH. Stability testing of new drug substances and products. Geneva: International Conference on Harmonization, IFPMA; 1993."},{"key":"9798_CR15","volume-title":"Impurities in new drug products","author":"ICH","year":"1996","unstructured":"ICH. Impurities in new drug products. Geneva: International Conference on Harmonization, IFPMA; 1996."},{"key":"9798_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.vascn.2007.05.006","volume":"56","author":"Y Hui","year":"2007","unstructured":"Hui Y, Huang NH, Ebbert L, Bina H, Chiang A, Maples C, Pritt M, Kern T, Patel N. Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs. J Pharmacol Toxicol Methods. 2007;56:256\u201364.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"9798_CR17","unstructured":"EMEA, The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on quality of modified release products. A: oral dosage forms. B: transdermal dosage forms, Section I (quality). 1999. CPMP\/QWP\/604\/96, 1\u201315."},{"key":"9798_CR18","unstructured":"USP 28, the United States Pharmacopoeia, 28th Revision. Rockville, MD: Pharmacopoeial Convention, Inc. 2005."},{"issue":"1","key":"9798_CR19","doi-asserted-by":"publisher","first-page":"Article 11","DOI":"10.1208\/ps060111","volume":"6","author":"DJ Burgess","year":"2004","unstructured":"Burgess DJ, Crommelin DJA, Hussain AS, Chen ML. Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS PharmSci. 2004;6(1):Article 11.","journal-title":"AAPS PharmSci"},{"issue":"3","key":"9798_CR20","first-page":"646","volume":"3","author":"AP Harshal","year":"2011","unstructured":"Harshal AP, Priscilla MD. Development and evaluation of herbal laxative granules. J Chem Pharm Res. 2011;3(3):646\u201350.","journal-title":"J Chem Pharm Res"},{"key":"9798_CR21","first-page":"154","volume-title":"Pharmaceutics: the science of dosage form design","author":"ME Aulton","year":"2002","unstructured":"Aulton ME. Pharmaceutics: the science of dosage form design. 2nd ed. New York: Churchill Livingstone; 2002. p. 154\u20135.","edition":"2"},{"key":"9798_CR22","first-page":"133","volume-title":"Pharmaceutics the science of dosage form design","author":"J Wells","year":"2003","unstructured":"Wells J. Pharmaceutical preformulation. In: Aulton ME, editor. Pharmaceutics the science of dosage form design. 2nd ed. Edinburgh: Churchill Livingstone; 2003. p. 133\u20134.","edition":"2"},{"issue":"3","key":"9798_CR23","first-page":"36","volume":"7","author":"I Haririan","year":"1999","unstructured":"Haririan I, Newton JM. Tensile strength of circular flat and convex-faced avicel PH102 tablets. Daru. 1999;7(3):36\u20139.","journal-title":"Daru"},{"key":"9798_CR24","unstructured":"USFDA. Dissolution methods database. 2010. \n                    accessdata.fda.gov\/scripts\/cder\/dissolution\n                    \n                  . Accessed on 15 Jun 2010."},{"key":"9798_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijpharm.2009.08.010","volume":"382","author":"Y Okuda","year":"2009","unstructured":"Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. A new formulation for orally disintegrating tablets using a suspension spray-coating method. Int J Pharm. 2009;382:80\u20137.","journal-title":"Int J Pharm"},{"key":"9798_CR26","unstructured":"USFDA. Bioequivalence guidelines. 2010. \n                    accessdata.fda.gov\/scripts\/cder\/dissolution\n                    \n                  . Accessed 15 Jun 2010."},{"key":"9798_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0378-4347(96)00125-9","volume":"685","author":"M Kobylifiska","year":"1996","unstructured":"Kobylifiska M, Kobylifiska K, Sobik B. High-performance liquid chromatographic analysis for the determination of miconazole in human plasma using solid phase extraction. J Chromatogr B Biomed Appl. 1996;685:191\u20135.","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"4","key":"9798_CR28","first-page":"94","volume":"31","author":"P Sheskey","year":"2007","unstructured":"Sheskey P, Keary C, Clark D, Balwinski K. Scale up formulae of foam granulation technology-high shear. Pharm Technol. 2007;31(4):94\u20139.","journal-title":"Pharm Technol"},{"issue":"3","key":"9798_CR29","first-page":"378","volume":"7","author":"V Barillaro","year":"2004","unstructured":"Barillaro V, Bertholet P, Sandrine HH. Effect of acidic ternary compounds on the formation of miconazole\/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J Pharm Pharm Sci. 2004;7(3):378\u201388.","journal-title":"J Pharm Pharm Sci"},{"key":"9798_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijpharm.2007.05.003","volume":"342","author":"V Barillaro","year":"2007","unstructured":"Barillaro V, Dive G, Bertholet P, Evrard B, Delattre L, Frederich M, Ziemons E, Piel G. Theoretical and experimental investigations of organic acids\/ cyclodextrin complexes and their consequences upon the formation of miconazole\/previous termcyclodextrin\/acid ternary inclusion complexes. Int J Pharm. 2007;342:152\u201360.","journal-title":"Int J Pharm"},{"key":"9798_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0378-5173(03)00157-1","volume":"258","author":"T Yoshinari","year":"2003","unstructured":"Yoshinari T, Forbes RT, York P, Kawashima Y. The improved compaction properties of mannitol after a moisture-induced polymorphic transition. Int J Pharm. 2003;258:121\u201331.","journal-title":"Int J Pharm"},{"key":"9798_CR32","unstructured":"Nie X. Heat and moisture migration within a porous urea particle bed. PhD thesis, University of Saskatchewan, 2010; p. 8\u20139."},{"key":"9798_CR33","unstructured":"USP, the United States Pharmacopoeia. 34th edn., Rockville, MD: Pharmacopoeial Convention, Inc. 2011."},{"issue":"7","key":"9798_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/jps.2600670716","volume":"67","author":"CF Lerk","year":"1978","unstructured":"Lerk CF, Lagas M, Fell JT, Nauta P. Effect of hydrophilization of hydrophobic drugs on release rate from capsules. J Pharm Sci. 1978;67(7):935\u20139.","journal-title":"J Pharm Sci"},{"key":"9798_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0378-5173(88)90265-7","volume":"48","author":"MR Jafari","year":"1988","unstructured":"Jafari MR, Danti AG, Ahmed I. Comparison of polyethylene glycol, polyvinylpyrrolidone and urea as excipients for solid dispersion systems of MN. Int J Pharm. 1988;48:207\u201315.","journal-title":"Int J Pharm"},{"key":"9798_CR36","unstructured":"ICH. International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use, by the ICH Steering Committee, version 2, 2005."},{"key":"9798_CR37","unstructured":"The European Pharmacopoeia (Ph.Eur.). 6th ed., Strasbourg, France: European Directorate for the Quality of Medicines, Council of Europe. 2010."},{"key":"9798_CR38","first-page":"E67","volume":"4","author":"D Faroongsarng","year":"2003","unstructured":"Faroongsarng D, Peck GE. Thermal porosity analysis of croscarmellose sodium and sodium starch glycolate by differential scanning calorimetry. AAPS Pharma Sci Tech. 2003;4:E67.","journal-title":"AAPS Pharma Sci Tech"},{"key":"9798_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0378-5173(94)00212-N","volume":"114","author":"L Stubberud","year":"1995","unstructured":"Stubberud L, Arwidsson HG, Graffner C. Water\u2013solid interactions: a technique for studying moisture sorption\/ desorption. Int J Pharm. 1995;114:55\u201364.","journal-title":"Int J Pharm"},{"key":"9798_CR40","first-page":"196","volume-title":"Handbook of pharmaceutical excipients","author":"RC Rowe","year":"2009","unstructured":"Rowe RC, Shesky PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 196\u20138.","edition":"6"},{"key":"9798_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2006.03.001","volume":"317","author":"SM Wong","year":"2006","unstructured":"Wong SM, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm. 2006;317:61\u20138.","journal-title":"Int J Pharm"},{"issue":"3","key":"9798_CR42","first-page":"378","volume":"7","author":"V Barillaro","year":"2004","unstructured":"Barillaro V, Bertholet P, Sandrine HH. Effect of acidic ternary compounds on the formation of miconazole\/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J Pharm Sci. 2004;7(3):378\u201388.","journal-title":"J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-012-9798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-012-9798-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-012-9798-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-012-9798-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:48:19Z","timestamp":1559605699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-012-9798-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9798"],"URL":"https:\/\/doi.org\/10.1208\/s12249-012-9798-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}